SCHEMBL13612101

SCHEMBL13612101

C[Si](C)(C)O[Si](CCCNC(=O)CBr)(O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HDAC3 O15379 2/20 0.36
HDAC4 P56524 2/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC7 Q8WUI4 2/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC10 Q969S8 2/20 0.36
HDAC11 Q96DB2 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
HDAC9 Q9UKV0 2/20 0.36
HDAC5 Q9UQL6 2/20 0.36
TSHR P16473 1/20 0.34
FAAH O00519 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 1/20 0.32
ADORA1 P30542 2/20 0.32
MTNR1A P48039 1/20 0.32
CASP2 P42575 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13612087 0.84 ALDH1A1 (0.52) MEN1KMT2ATSHRFAAHSMN1; SMN2
SCHEMBL22864130 0.84 MEN1 (0.57) MEN1KMT2AMTNR1ACASP2
SCHEMBL6289357 0.81 TSHR (0.40) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL276131 0.81 MEN1 (0.39) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL1402612 0.79 KDM4E (0.32) MEN1KMT2ATSHRCYP2C19HPGD
SCHEMBL12451661 0.79 KDM4E (0.52) TSHRSMN1; SMN2ALDH1A1MTNR1A
SCHEMBL502431 0.79 MEN1 (0.41) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL5916828 0.78 EPHX1 (0.50) MEN1KMT2ATSHR
SCHEMBL13784565 0.77 MEN1 (0.32) MEN1KMT2ATSHR
SCHEMBL9717442 0.76 KDM4E (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622512-B2 Cationic hydrophilic siloxanyl monomers BAUSCH & LOMB INCORPORATED (US) 2009-11-24 US disclosed
US-20080152540-A1 PACKAGING SOLUTIONS BAUSCH & LOMB INCORPORATED (US) 2008-06-26 US disclosed
US-20070142583-A1 Cationic hydrophilic siloxanyl monomers ECR PHARMACEUTICALS CO., INC. 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142583-A1 Cationic hydrophilic siloxanyl monomers STIM1, ILK, AAAS MEN1 1792/4885KMT2A 3301/4885HDAC3 2594/4885
US-20080152540-A1 PACKAGING SOLUTIONS AQP1, ARGLU1, CRYZ MEN1 2673/4885KMT2A 3462/4885HDAC3 2840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.